Literature DB >> 22283316

Synthesis of the first highly potent bridged nicotinoid 9-Azabicyclo[4.2.1]nona[2,3-c]pyridine (pyrido[3,4-b]homotropane).

D B Kanne, D J Ashworth, M T Cheng, L C Mutter, L G Abood.   

Abstract

Entities:  

Year:  1986        PMID： 22283316     DOI： 10.1021/ja00284a078

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN： 0002-7863            Impact factor:   15.419


× No keyword cloud information.
  3 in total

1.  In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.

Authors:  F Ivy Carroll; Hernán A Navarro; S Wayne Mascarella; Ana H Castro; Charles W Luetje; Charles R Wageman; Michael J Marks; Asti Jackson; M Imad Damaj
Journal:  ACS Chem Neurosci       Date:  2015-04-30       Impact factor: 4.418

2.  Synthesis of New Functionally Substituted 9-Azabicyclo[4.2.1]nona-2,4,7-trienes by Cobalt(I)-Catalyzed [6π + 2π]-Cycloaddition of N-Carbocholesteroxyazepine to Alkynes.

Authors:  Gulnara N Kadikova; Vladimir A D'yakonov; Usein M Dzhemilev
Journal:  Molecules       Date:  2021-05-14       Impact factor: 4.411

Review 3.  Synthetic Methods for the Preparation of Conformationally Restricted Analogues of Nicotine.

Authors:  Biswajit Panda; Gianluigi Albano
Journal:  Molecules       Date:  2021-12-13       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.